Compare Abeona Therapeutics Inc (ABEO) vs Innovative Industrial Properties Inc (IIPR) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Innovative Industrial Properties Inc — how do they compare? Abeona Therapeutics Inc trades at $6.74 (market cap $373.32M), while Innovative Industrial Properties Inc trades at $62.53 (market cap $1.79B). The key difference: Innovative Industrial Properties Inc is far larger — about 4.8× Abeona Therapeutics Inc's market cap, and Innovative Industrial Properties Inc pays a 12.3% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | IIPR | |
|---|---|---|
Market Cap | $373.32M | $1.79B |
Sector | Health | Real Estate |
52-Week High | $7.23 | $63.40 |
52-Week Low | $4.17 | $44.58 |
Enterprise Value | $228.22M | $2.18B |
Dividend Yield | — | 12.3% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
IIPR trades at $61.81, down 2.51% on the day, with a bullish technical signal from moving averages and a neutral RSI. The company reported a Q1 2026 EPS beat of $1.88 versus $1.07 expected, though revenue has declined from $310M in 2023 to $266M in 2025. Recent news highlights progress on cannabis rescheduling as a potential tailwind and the declaration of a $1.90 dividend for Q2 2026.
The outlook is mixed; a high dividend yield and low P/E of 15.78 offer value, but declining revenue and negative net cash flow pose risks. Analyst sentiment is cautious with a majority Hold rating. Upside depends on stabilizing tenant operations and regulatory progress, while downside risks include further revenue pressure and sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Innovative Industrial Properties Inc
Innovative Industrial Properties Inc is a real estate investment trust engaged in the acquisition, ownership, and management of specialized industrial properties leased to state-licensed operators for their regulated medical-use cannabis facilities. It conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by Operating Partnership, directly or through subsidiaries. Its property portfolio is spread across the United States.
Read more on IIPR →
